1. Home
  2. BGLC vs VCIG Comparison

BGLC vs VCIG Comparison

Compare BGLC & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • VCIG
  • Stock Information
  • Founded
  • BGLC 2017
  • VCIG 2013
  • Country
  • BGLC Malaysia
  • VCIG Malaysia
  • Employees
  • BGLC N/A
  • VCIG N/A
  • Industry
  • BGLC Medical Specialities
  • VCIG Diversified Commercial Services
  • Sector
  • BGLC Health Care
  • VCIG Consumer Discretionary
  • Exchange
  • BGLC Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • BGLC 7.8M
  • VCIG 7.5M
  • IPO Year
  • BGLC N/A
  • VCIG 2023
  • Fundamental
  • Price
  • BGLC $4.39
  • VCIG $1.17
  • Analyst Decision
  • BGLC
  • VCIG
  • Analyst Count
  • BGLC 0
  • VCIG 0
  • Target Price
  • BGLC N/A
  • VCIG N/A
  • AVG Volume (30 Days)
  • BGLC 126.1K
  • VCIG 9.2M
  • Earning Date
  • BGLC 11-14-2025
  • VCIG 10-06-2025
  • Dividend Yield
  • BGLC N/A
  • VCIG N/A
  • EPS Growth
  • BGLC N/A
  • VCIG N/A
  • EPS
  • BGLC N/A
  • VCIG 0.98
  • Revenue
  • BGLC $9,465,006.00
  • VCIG $32,903,041.00
  • Revenue This Year
  • BGLC N/A
  • VCIG N/A
  • Revenue Next Year
  • BGLC N/A
  • VCIG N/A
  • P/E Ratio
  • BGLC N/A
  • VCIG $1.17
  • Revenue Growth
  • BGLC 2.21
  • VCIG 24.77
  • 52 Week Low
  • BGLC $2.01
  • VCIG $0.91
  • 52 Week High
  • BGLC $15.60
  • VCIG $4,644.01
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 37.35
  • VCIG 37.10
  • Support Level
  • BGLC $4.35
  • VCIG $1.07
  • Resistance Level
  • BGLC $4.94
  • VCIG $1.28
  • Average True Range (ATR)
  • BGLC 0.28
  • VCIG 0.26
  • MACD
  • BGLC -0.06
  • VCIG 0.10
  • Stochastic Oscillator
  • BGLC 11.24
  • VCIG 17.86

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

Share on Social Networks: